Reported Jan 11, 2017 · Terminated
Tri 1 (PAP/PHEN/ATROPINE) NR Injectable, 3.6 mg/0.4 mg/0.04 mg/mL, a) 2 mL and b) 5 mL vials, Compounded by Wells…
Wells Pharmacy Network LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Wells Pharmacy Network LLC · 1210 SW 33rd Ave · Ocala, FL · 34474-2853
Is this the product you have?
- Tri 1 (PAP/PHEN/ATROPINE) NR Injectable, 3.6 mg/0.4 mg/0.04 mg/mL, a) 2 mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL
- Lot codes and dates
3 of 3 products
Products covered by this recall # Product as published 1 lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry. a) Known 2 lot code: 04072016@10, 05102016@18, 06232016@12, 08182016@26 b) Known 3 lot code: 04122016@19, 05042016@18, 06142016@43, 07122016@40, 07262016@47. - Amount recalled
- a) 257 vials and b) 460 vials
This recall covers 97 products
The agency filed one notice per product. You are reading one of them; the other 96 are below.
84 more are in the archive.
Where it was sold
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Wells Pharmacy Network LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.